LOXO ONCOLOGY INC's ticker is LOXO and the CUSIP is 548862101. A total of 213 filers reported holding LOXO ONCOLOGY INC in Q2 2018. The put-call ratio across all filers is 0.64 and the average weighting 0.6%.
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aisling Capital LLC | 3,452,493 | $45,330,000 | 8.79% |
| BVF INC/IL | 1,192,202 | $15,654,000 | 3.25% |
| Redmile Group, LLC | 540,300 | $7,094,000 | 0.82% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,591,546 | $20,897,000 | 0.76% |
| Orbimed Advisors | 2,175,857 | $28,569,000 | 0.30% |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 365,566 | $4,800,000 | 0.18% |
| MARXE AUSTIN W & GREENHOUSE DAVID M | 75,000 | $985,000 | 0.13% |
| RS INVESTMENT MANAGEMENT CO LLC | 599,400 | $7,870,000 | 0.07% |
| Visium Asset Management, LP | 332,516 | $4,366,000 | 0.06% |
| Nicholas Investment Partners, LP | 73,341 | $963,000 | 0.06% |